申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
公开号:EP0812589A1
公开(公告)日:1997-12-17
A combined antipyretic analgesic drug having an excellent antipyretic analgesic effect and reduced side effects, such as gastrointestinal disorder, and comprising a combination of ibusprofen with isopropylantipyrine in a ratio by weight of preferably 5:1 to 1:5, still preferably 3:1 to 1:3. Preferable examples of the dosage form include a three-layer tablet comprising the first layer containing ibusprofen and the third layer containing isopropylantipyrine and, sandwiched between these layers, the second layer containing an inactive ingredient, and a dry coated tablet having, enclosed therein, a core tablet containing ibuprofen or isopropylantipyrine.
一种解热镇痛联合用药,具有良好的解热镇痛效果,减少副作用,如胃肠功能紊乱,由伊布洛芬和异丙基安替比林组成,其重量比最好为5:1至1:5,最好为3:1至1:3。优选的剂型包括三层片剂,第一层含有布洛芬,第三层含有异丙基安替比林,夹在这两层之间的第二层含有非活性成分,以及干包衣片剂,其中包有含有布洛芬或异丙基安替比林的片芯。